NCT07586670

Brief Summary

The costoclavicular approach of the infraclavicular brachial plexus block is widely used for upper extremity surgeries due to its reliable anatomy and high success rates. Patient positioning, particularly the degree of arm abduction, may influence the spread of local anesthetic and the characteristics of the block. However, the optimal arm abduction angle during this procedure remains unclear. This prospective randomized controlled trial aims to investigate the effect of two different arm abduction angles (90° and 120°) on block onset time and block success in patients undergoing hand, wrist, and forearm surgery under ultrasound-guided costoclavicular brachial plexus block. Patients will be randomly assigned to one of two groups according to the degree of arm abduction. The primary outcome is block onset time. Secondary outcomes include block success, sensory and motor block characteristics, perfusion index changes, hemodynamic parameters, readiness for surgery at 15 and 20 minutes, block performance time, need for additional anesthesia, postoperative neurological evaluation at 4 and 24 hours, complications, and patient satisfaction. The findings of this study are expected to provide evidence on optimal patient positioning to improve the effectiveness and reliability of ultrasound-guided costoclavicular brachial plexus block.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started May 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
May 2026Aug 2026

First Submitted

Initial submission to the registry

April 7, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

May 15, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2026

Last Updated

June 9, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

April 7, 2026

Last Update Submit

June 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Block Onset Time

    Time from completion of local anesthetic injection to achievement of adequate sensory block sufficient for surgery, assessed by pinprick test.

    Up to 30 minutes after block performance

Secondary Outcomes (16)

  • Block Success

    İntraoperative period

  • Sensory Block Score

    Baseline and at 5-minute intervals up to 20 minutes after block performance.

  • Motor Block Score

    Baseline and at 5-minute intervals up to 30 minutes after block performance.

  • Perfusion Index

    Baseline and at 5,10,15 and 20 minutes after block performance.

  • Readiness for Surgery

    15 minutes after block

  • +11 more secondary outcomes

Study Arms (2)

90° Arm Abduction

EXPERIMENTAL

Patients receive ultrasound-guided costoclavicular brachial plexus block with the arm positioned at 90° abduction.

Procedure: Costoclavicular Brachial Plexus Block

120° Arm Abduction

EXPERIMENTAL

Patients receive ultrasound-guided costoclavicular brachial plexus block with the arm positioned at 120° abduction.

Procedure: Costoclavicular Brachial Plexus Block

Interventions

Ultra-sound Guided costoclavicular brachial plexus block performed for upper extremity surgery using a standard local anesthetic technique

120° Arm Abduction90° Arm Abduction

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 18 and 80 years.
  • Patients scheduled for elective upper extremity surgery (hand, wrist, forearm).
  • Patients classified as ASA I-III.
  • Patients who provide informed consent after being informed about the study.

You may not qualify if:

  • History of previous surgery, scar tissue, tumor, or trauma that may alter brachial plexus anatomy.
  • Presence of infection, hematoma, severe edema, burn, or open wound at the block application site.
  • Known allergy to local anesthetics or other medications used in the study.
  • Coagulopathy, use of anticoagulants, or platelet count \< 100,000/mm³.
  • History of peripheral neuropathy, neurological deficit, cervical radiculopathy, or CRPS.
  • Pregnancy or breastfeeding.
  • Patients with BMI \< 18 kg/m².
  • Patients with BMI \> 35 kg/m².
  • Severe cardiac, pulmonary, renal, or hepatic failure.
  • Mental retardation, communication difficulties, or lack of cooperation.
  • Deformity, amputation, or large mass in the surgical extremity that may interfere with sensorimotor assessment.
  • Preoperative significant sensory loss, motor weakness, or signs of neurological disease.
  • Severe anemia (Hb \< 9 g/dL) or polycythemia (Hb \> 18 g/dL).
  • Psychiatric disorders, substance abuse, or any condition that may interfere with study compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Reyhan Polat, Professor

    Ankara Etlik City Hospital

    STUDY DIRECTOR

Central Study Contacts

Algan TURGUT ÇARSANCAKLI, M.D.

CONTACT

Reyhan POLAT, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study is an open-label trial. Due to the nature of the intervention (different arm positions), blinding is not feasible
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups based on the degree of arm abduction (90° or 120°) during ultrasound-guided costoclavicular brachial plexus block. Outcomes will be compared between the two groups.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 7, 2026

First Posted

May 14, 2026

Study Start

May 15, 2026

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

August 27, 2026

Last Updated

June 9, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share